Supplement maker Promisia plans US launch after clinical trial and turns to dogs

Supplement maker Promisia plans US launch after clinical trial and turns to dogs
By Fiona Rotherham May 28 (BusinessDesk) - Promisia Integrative, which sells a dietary supplement to treat painful joint conditions like arthritis, is about to launch into the US market and test its product on dogs after positive preliminary results from its first human clinical trial. The Wellington-based listed company said this week that preliminary results from the 12-week trial conducted by the Rheumatology Research Unit at Otago University showed its supplement, Arthrem, provided significant benefits for research participants aged b...